Literature DB >> 1885764

Maple syrup urine disease in Mennonites. Evidence that the Y393N mutation in E1 alpha impedes assembly of the E1 component of branched-chain alpha-keto acid dehydrogenase complex.

C R Fisher1, J L Chuang, R P Cox, C W Fisher, R A Star, D T Chuang.   

Abstract

Maple Syrup Urine Disease (MSUD) in Mennonites is associated with homozygosity for a T to A transversion in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex. This causes a tyrosine to asparagine substitution at position 393 (Y393N). To assess the functional significance of this missense mutation, we have carried out transfection studies using E1 alpha-deficient MSUD lymphoblasts (Lo) as a host. The level of E1 beta subunit is also greatly reduced in Lo cells. Efficient episomal expression in lymphoblasts was achieved using the EBO vector. The inserts employed were chimeric bovine-human cDNAs which encode mitochondrial import competent E1 alpha subunit precursors. Transfection with normal E1 alpha cDNA into Lo cells restored decarboxylation activity of intact cells. Western blotting showed that both E1 alpha and E1 beta subunits were markedly increased. Introduction of Y393N mutant E1 alpha cDNA failed to produce any measurable decarboxylation activity. Mutant E1 alpha subunit was expressed at a normal level, however, the E1 beta subunit was undetectable. These results provide the first evidence that Y393N mutation is the cause of MSUD. Moreover, this mutation impedes the assembly of E1 alpha with E1 beta into a stable alpha 2 beta 2 structure, resulting in the degradation of the free E1 beta subunit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885764      PMCID: PMC295513          DOI: 10.1172/JCI115363

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance.

Authors:  J H MENKES; P L HURST; J M CRAIG
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

Review 2.  The 2-oxo acid dehydrogenase complexes: recent advances.

Authors:  S J Yeaman
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Molecular cloning of a cDNA for the E1 alpha subunit of rat liver branched chain alpha-ketoacid dehydrogenase.

Authors:  B Zhang; M J Kuntz; G W Goodwin; R A Harris; D W Crabb
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

4.  Enzyme assays with mutant cell lines of maple syrup urine disease.

Authors:  D T Chuang; R P Cox
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  Structure of the gene encoding the entire mature E1 alpha subunit of human branched-chain alpha-keto acid dehydrogenase complex.

Authors:  N Dariush; C W Fisher; R P Cox; D T Chuang
Journal:  FEBS Lett       Date:  1991-06-17       Impact factor: 4.124

6.  Localization of the dihydrolipoamide branched-chain transacylase gene (DBT) of the human branched-chain keto acid dehydrogenase complex to chromosome 1.

Authors:  K S Lau; R L Eddy; T B Shows; C W Fisher; D T Chuang; R P Cox
Journal:  Cytogenet Cell Genet       Date:  1991

7.  Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells.

Authors:  R F Margolskee; P Kavathas; P Berg
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

8.  Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.

Authors:  B Zhang; H J Edenberg; D W Crabb; R A Harris
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

9.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

10.  Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency.

Authors:  I D Wexler; D S Kerr; L Ho; M M Lusk; R A Pepin; A A Javed; J E Mole; B W Jesse; T J Thekkumkara; G Pons
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more
  13 in total

1.  Maple syrup urine disease: the E1beta gene of human branched-chain alpha-ketoacid dehydrogenase complex has 11 rather than 10 exons, and the 3' UTR in one of the two E1beta mRNAs arises from intronic sequences.

Authors:  J L Chuang; R P Cox; D T Chuang
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 2.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Carrier detection and rapid newborn diagnostic test for the common Y393N maple syrup urine disease allele by PCR-RFLP: culturally permissible testing in the Mennonite community.

Authors:  L D Love-Gregory; J A Dyer; J Grasela; R E Hillman; C L Phillips
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

4.  Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.

Authors:  J L Chuang; C R Fisher; R P Cox; D T Chuang
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Biochemical correlates of neuropsychiatric illness in maple syrup urine disease.

Authors:  Emilie R Muelly; Gregory J Moore; Scott C Bunce; Julie Mack; Don C Bigler; D Holmes Morton; Kevin A Strauss
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

6.  Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit.

Authors:  Theodoros Georgiou; Jacinta L Chuang; R Max Wynn; Goula Stylianidou; Mark Korson; David T Chuang; Anthi Drousiotou
Journal:  Genet Test Mol Biomarkers       Date:  2009-10

7.  Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.

Authors:  C W Fisher; C R Fisher; J L Chuang; K S Lau; D T Chuang; R P Cox
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

8.  Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.

Authors:  Tamara S Roman; Stephanie B Crowley; Myra I Roche; Ann Katherine M Foreman; Julianne M O'Daniel; Bryce A Seifert; Kristy Lee; Alicia Brandt; Chelsea Gustafson; Daniela M DeCristo; Natasha T Strande; Lori Ramkissoon; Laura V Milko; Phillips Owen; Sayanty Roy; Mai Xiong; Ryan S Paquin; Rita M Butterfield; Megan A Lewis; Katherine J Souris; Donald B Bailey; Christine Rini; Jessica K Booker; Bradford C Powell; Karen E Weck; Cynthia M Powell; Jonathan S Berg
Journal:  Am J Hum Genet       Date:  2020-08-26       Impact factor: 11.025

9.  Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.

Authors:  J L Chuang; J R Davie; J M Chinsky; R M Wynn; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Stable correction of maple syrup urine disease in cells from a Mennonite patient by retroviral-mediated gene transfer.

Authors:  H Koyata; R P Cox; D T Chuang
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.